Title:Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19
Volume: 21
Issue: 2
Author(s): Mohammad Amin Shahrbaf, Mohammadreza Tabary and Isa Khaheshi*
Affiliation:
- Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran,Iran
Keywords:
Remdesivir, favipiravir, COVID-19, heart, cardiovascular, side effect.
Abstract: After the outbreak of COVID-19, many novel drugs have been introduced to improve patients’
conditions. Remdesivir and Favipiravir are among the most common drugs used against
SARS-CoV-2. Although promising, cardiovascular side effects of these drugs should be considered
by physicians and nurses. In this study, we searched databases for assessing the cardiovascular side
effects of Remdesivir and Favipiravir. It seems that despite the beneficial effects of these drugs,
due to the cardiovascular complications of COVID-19 and cardiovascular side effects of these
drugs, which can overlap with each other, the use of these drugs can be a challenging issue in the
cardiovascular practice.
